Francesco Maria Lavino, Chief Commercial Officer

NBRV 185,393 shares

The estimated Net Worth of Francesco Maria Lavino is at least $98,814.47. Francesco Maria Lavino owns over 185,393 units of Nabriva Therapeutics Plc stock worth over $98,814.47.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
30th September 2020NBRV - Nabriva Therapeutics Plc366Payment by withholding185,393$0.53$195.08$98,814.47
21st August 2019NBRV - Nabriva Therapeutics Plc3,797Payment by withholding11,172$2.08$7,897.76$23,237.76
19th August 2019NBRV - Nabriva Therapeutics Plc11,250Exercise of derivative14,969$0.00
22nd August 2019NBRV - Nabriva Therapeutics Plc4,800Open or private purchase15,972$2.04$9,780.00$32,542.95
31st January 2020NBRV - Nabriva Therapeutics Plc3,892Payment by withholding75,830$1.35$5,254.20$102,370.50
6th February 2020NBRV - Nabriva Therapeutics Plc105,000Grant/award etc.180,830$0.00
28th February 2020NBRV - Nabriva Therapeutics Plc366Payment by withholding180,464$1.35$494.10$243,626.40
31st March 2020NBRV - Nabriva Therapeutics Plc366Payment by withholding180,098$0.58$210.45$103,556.35
30th April 2020NBRV - Nabriva Therapeutics Plc366Payment by withholding179,732$0.55$200.68$98,547.06
31st May 2020NBRV - Nabriva Therapeutics Plc366Payment by withholding179,366$1.14$417.24$204,477.24
30th June 2020NBRV - Nabriva Therapeutics Plc366Payment by withholding179,000$0.67$246.90$120,753.40
31st July 2020NBRV - Nabriva Therapeutics Plc366Payment by withholding178,634$0.76$278.16$135,761.84
20th August 2020NBRV - Nabriva Therapeutics Plc3,759Payment by withholding186,125$0.65$2,434.33$120,534.55
19th August 2020NBRV - Nabriva Therapeutics Plc11,250Exercise of derivative189,884$0.00
31st August 2020NBRV - Nabriva Therapeutics Plc366Payment by withholding185,759$0.62$226.70$115,059.12